Dabrafenib 75mg Capsule (LuciDabra) Price in Pakistan | Impo Medic
₨ 0
Description
Dabrafenib 75mg Capsule (LuciDabra) Price in Pakistan
Dabrafenib 75mg Capsule (LuciDabra) contains dabrafenib, a targeted anticancer medicine classified as a BRAF kinase inhibitor. It is used for certain cancers associated with specific BRAF gene mutations, particularly BRAF V600E and V600K mutations.
LuciDabra 75mg is manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd. It is designed for specialist-directed treatment of selected patients with melanoma and other BRAF mutation-positive cancers.
Uses of Dabrafenib 75mg
Dabrafenib may be prescribed for eligible patients with:
- Melanoma: Unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, depending on whether it is used alone or with trametinib.
- Non-Small Cell Lung Cancer (NSCLC): Metastatic BRAF V600E mutation-positive NSCLC, in combination with trametinib.
- Anaplastic Thyroid Cancer: Locally advanced or metastatic BRAF V600E mutation-positive thyroid cancer when satisfactory local treatment options are unavailable, in combination with trametinib.
- Adjuvant Melanoma Treatment: Selected patients with BRAF V600E or V600K mutation-positive melanoma following complete surgical removal, in combination with trametinib.
Treatment eligibility depends on the cancer diagnosis, mutation status and applicable prescribing information.
How Dabrafenib Works
Dabrafenib blocks abnormal BRAF kinase activity, particularly in cancer cells carrying certain BRAF mutations. These mutations can activate the MAPK signalling pathway, which promotes uncontrolled cell growth and multiplication.
By inhibiting mutated BRAF proteins, dabrafenib helps slow cancer-cell growth. It may be combined with trametinib, a MEK inhibitor, to target another part of the same signalling pathway.
Dosage and Administration
The appropriate dabrafenib dose depends on the cancer type, treatment combination, patient characteristics and response to therapy.
For adults receiving dabrafenib capsules, the commonly recommended dose in the prescribing information is 150mg twice daily. The 75mg capsule is one available strength used to achieve the prescribed dose.
- Take the medicine exactly as directed by the treating oncologist.
- Dabrafenib capsules should generally be taken at least 1 hour before or 2 hours after a meal.
- Swallow capsules whole with water.
- Do not chew, open or crush the capsules.
- When prescribed with trametinib, follow the treatment instructions for both medicines.
Do not change the dose or interrupt treatment without consulting the treating oncologist.
Precautions
- Confirm the relevant BRAF mutation through an appropriate validated tumour test before starting treatment.
- Dabrafenib should be initiated and monitored by an oncologist experienced in targeted cancer therapy.
- Treatment can cause serious fever-related reactions and requires appropriate medical assessment.
- Patients should undergo skin examinations and monitoring for new primary malignancies.
- Blood glucose monitoring may be necessary, particularly in patients with diabetes.
- Report new vision changes, eye pain or inflammation to the treating physician.
- Dabrafenib may interact with several medicines by affecting drug-metabolising enzymes, including CYP3A4.
- It may cause fetal harm. Pregnancy prevention and contraception should be discussed with the treating specialist.
- Inform the oncologist about all existing medical conditions, medicines and supplements.
Product Information
- Product Name: Dabrafenib 75mg Capsule
- Brand Name: LuciDabra
- Generic Name: Dabrafenib
- Strength: 75mg
- Dosage Form: Capsule
- Pack Size: 120 Capsules
- Manufacturer: Lucius Pharmaceuticals (Lao) Co., Ltd.
- Country of Manufacture: Laos
FAQs about Dabrafenib 75mg Capsule (LuciDabra) Price in Pakistan
What is Dabrafenib 75mg Capsule used for?
Dabrafenib is a targeted anticancer medicine used for selected BRAF mutation-positive cancers, including certain types of melanoma, lung cancer and anaplastic thyroid cancer.
What is LuciDabra 75mg?
LuciDabra 75mg is a branded dabrafenib capsule manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd.
Is Dabrafenib a targeted therapy?
Yes. Dabrafenib is a BRAF kinase inhibitor that targets abnormal signalling associated with specific BRAF gene mutations.
Does Dabrafenib require BRAF mutation testing?
Yes. Appropriate tumour testing is required to identify patients who may benefit from dabrafenib treatment.
Can Dabrafenib be used with Trametinib?
Yes. The combination of dabrafenib and trametinib is used for several BRAF mutation-positive cancer indications under specialist supervision.
How many capsules are included in a LuciDabra pack?
The manufacturer’s listed pack contains 120 capsules of Dabrafenib 75mg.
Does Dabrafenib require a prescription?
Yes. It is a prescription anticancer medicine requiring oncologist supervision and appropriate monitoring.
Dabrafenib 75mg in Pakistan
Customers searching for Dabrafenib 75mg Capsule (LuciDabra) in Pakistan can contact Impo Medic for product information and order-related assistance. For queries about Dabrafenib 75mg Capsule (LuciDabra) Price in Pakistan, LuciDabra 75mg availability, or imported Dabrafenib capsules, product details and supply can be confirmed directly with the team. Prescription requirements apply.

Reviews
There are no reviews yet.